Jul 8, 2024, 13:58
Shilpa Gupta: Amazing multidisciplinary session on penile cancer
Shilpa Gupta shared on X:
“Amazing multi-D session on penile cancer in Greece
The master Andrea Necchi discusses systemic Tx in penile ca. Shout out to Dr. Lance Pagliaro for initial chemo trial and IO-based trials trials by André P. Fay et al. and Andrea Apolo setting the stage for IO-based regimes and use of biomarkers.”
Source: Shilpa Gupta/X
Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 06:51
Nov 20, 2024, 01:07
Nov 20, 2024, 01:00
Nov 20, 2024, 00:40
Nov 20, 2024, 00:31
Nov 20, 2024, 00:29